Cargando…
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
Autores principales: | Bichard, Christian, Mancini, Ilaria, Agosti, Pasquale, Capecchi, Marco, De Leo, Pasqualina, Arcudi, Sara, Ferrari, Barbara, Trisolini, Silvia Maria, Longu, Francesco, Fozza, Claudio, Artoni, Andrea, Peyvandi, Flora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631697/ https://www.ncbi.nlm.nih.gov/pubmed/35772164 http://dx.doi.org/10.1182/bloodadvances.2022007632 |
Ejemplares similares
-
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023) -
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
por: Riva, Silvia, et al.
Publicado: (2020) -
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
por: Capecchi, Marco, et al.
Publicado: (2023) -
Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19
por: Capecchi, Marco, et al.
Publicado: (2020) -
Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study
por: Ferrari, Barbara, et al.
Publicado: (2014)